Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Mohanad M. Elfishawi"'
Autor:
Mohanad M. Elfishawi, Mahmut S. Kaymakci, Ying‐Chun Lo, Philip A. Araoz, Matthew J. Koster, Kenneth J. Warrington
Publikováno v:
ACR Open Rheumatology, Vol 6, Iss 4, Pp 201-202 (2024)
Externí odkaz:
https://doaj.org/article/5e142f695e5f4a90b94d14699bf1b575
Autor:
Kenneth J Warrington, Tanaz A Kermani, Mohanad M Elfishawi, Mahmut S Kaymakci, Sara J Achenbach, Cynthia S Crowson, Cornelia M Weyand, Matthew J Koster
Publikováno v:
RMD Open, Vol 10, Iss 1 (2024)
Objective To evaluate the incidence and outcomes of large artery (LA) involvement among patients with giant cell arteritis (GCA) and to compare LA involvement to non-GCA patients.Methods The study included Olmsted County, Minnesota, USA residents wit
Externí odkaz:
https://doaj.org/article/b6eaaff5286e43538aef9073e39c0b29
Publikováno v:
ACR Open Rheumatology, Vol 6, Iss 1, Pp 3-3 (2024)
Externí odkaz:
https://doaj.org/article/5b2687cf509c4bfbb86bd3862ac03541
Autor:
Sunam M. Sujanani, Mohanad M. Elfishawi, Paria Zarghamravanbaksh, Francisco J. Cuevas Castillo, David M. Reich
Publikováno v:
Case Reports in Endocrinology, Vol 2020 (2020)
Sodium-glucose cotransporter 2 (SGLT2) inhibitors are increasingly used as add-on therapy in patients with poorly controlled type 2 diabetes mellitus (T2DM). Although pancreatitis is not a known side effect of SGLT-2 inhibitors, there have been case
Externí odkaz:
https://doaj.org/article/9d152e4db6da46c2a806efbf640b88ff
Autor:
Sally Elfishawi, Mohanad M. Elfishawi
Publikováno v:
Translational Autoimmunity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::94e32388414ba1d50803b5b09ad41b94
https://doi.org/10.1016/b978-0-12-822564-6.00015-x
https://doi.org/10.1016/b978-0-12-822564-6.00015-x
Autor:
Nour Zleik, Cynthia S. Crowson, Mohanad M. Elfishawi, Zoran Kvrgic, Eric L. Matteson, Clement J. Michet, Tim Bongartz
Publikováno v:
J Rheumatol
Objective.To examine whether a change in the presentation of incident gout happened over the last 20 years and to determine the risk of subsequent gout flares after an initial gout attack.Methods.All incident cases of gout were identified among resid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::106754b57d85f3108afe9ae52b8a5691
https://doi.org/10.3899/jrheum.190346
https://doi.org/10.3899/jrheum.190346
Publikováno v:
British Journal of Surgery. 108
Lung cancer is the most common cancer worldwide and has highest cancer mortality. Around 50% of cases present with metastasis, however skeletal muscle metastasis is rarely reported. In this case we describe a fifty-nine-year-old male patient who pres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b04a7efd82f0650cfb666f4224880c0
https://doi.org/10.1093/bjs/znab134.260
https://doi.org/10.1093/bjs/znab134.260
Autor:
H de Bruin, Mohanad M. Elfishawi, Marcelo Fernandez-Vina, Paul Norman, Gonzalo Montero-Martín, Danillo G. Augusto, Jill A. Hollenbach, Sally Elfishawi, Erik H. Rozemuller, Ghada I. Mossallam, K Zaky, L Van de Pasch, Adriana Abrudescu
Publikováno v:
Clin Exp Immunol
Summary Behçet disease is a multi-system disease associated with human leukocyte antigen (HLA) class I polymorphism. High-resolution next-generation sequencing (NGS) with haplotype analysis has not been performed previously for this disease. Sixty E
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccc51e57f94bcf93918ff3fe3e462157
https://europepmc.org/articles/PMC7944360/
https://europepmc.org/articles/PMC7944360/
Publikováno v:
Case Reports in Gastrointestinal Medicine, Vol 2020 (2020)
Case Reports in Gastrointestinal Medicine
Case Reports in Gastrointestinal Medicine
Intestinal pseudo-obstruction (IPO) is a rarely recognized complication of systemic lupus erythematosus (SLE). We present a 36-year-old African American female, with only known past medical history of anemia, admitted for frequent vomiting, abdominal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0b1c3b6c2c755cae5a632376ad2bfab
https://doaj.org/article/0858515e5e914d53a4021f9e9c92d8e0
https://doaj.org/article/0858515e5e914d53a4021f9e9c92d8e0
Autor:
Samar Abohamad, Kadambari Vijaykumar, Mohanad M. Elfishawi, Hamdy M. Ahmed, Mohamed Tharwat Hegazy
Publikováno v:
Patient preference and adherence
Belimumab is a novel add-on therapy that has been approved for patients with active and antibody-mediated systemic lupus erythematosus. It is a monoclonal antibody that decreases the activation of B-cells and consequently decreases antibodies' produc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::228217324f9720793fe23cd8246b6d76
https://doi.org/10.2147/ppa.s147163
https://doi.org/10.2147/ppa.s147163